Daniela M Caserta, in Barre, VT - Marriage & Family Therapist

Daniela M Caserta, is a Marriage & Family Therapist based in Barre, Vermont. Daniela M Caserta is licensed to practice in * (Not Available) (license number ) and her current practice location is 21 Merchant St, Barre, Vermont. She can be reached at her office (for appointments etc.) via phone at (802) 522-9770.

NPI number for Daniela M Caserta is 1558978239 and her current mailing address is 21 Merchant St, Barre, Vermont. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1558978239.

Contact Information

	Daniela M Caserta,
	21 Merchant St, Barre, VT 05641-3871
	(802) 522-9770
	Not Available

Healthcare Provider's Profile

Full Name	Daniela M Caserta
Gender	Female
Speciality	Marriage & Family Therapist
Location	21 Merchant St, Barre, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1558978239
Provider Enumeration Date: 09/28/2020
Last Update Date: 09/28/2020

Medical Identifiers

Medical identifiers for Daniela M Caserta such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1558978239	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
106H00000X	Marriage & Family Therapist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Daniela M Caserta is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Daniela M Caserta, 21 Merchant St, Barre, VT 05641-3871 Ph: () -	Daniela M Caserta, 21 Merchant St, Barre, VT 05641-3871 Ph: (802) 522-9770

News Archive

Study: Hormonal maintenance therapy may improve survival in women with low-grade serous carcinoma

For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma, hormone maintenance therapy may significantly improve survival, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.

OMRF scientist selected to receive EMD Serono's Grant for Multiple Sclerosis Innovation

An Oklahoma Medical Research Foundation scientist has been selected to receive one of only five Grants for Multiple Sclerosis Innovation awarded this year by the pharmaceutical company EMD Serono.

CTCs in metastatic breast cancer patients linked to cancer recurrence, poor survival rates

Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor outcomes, according to researchers from the University of Texas MD Anderson Cancer Center.

FDA grants IDE approval to STS and ACC to study alternative access approaches for TAVR

The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC) have received a unique investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to study "alternative access" approaches for transcatheter aortic valve replacement (TAVR) using the STS/ACC TVT Registry.

Daniela M Caserta, - Couples Therapy in Barre, VT